CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological,
and molecular characteristics wit Page 1 Radiology and Oncology | Ljubljana | Slovenia …

Background: Various subsets of diffuse large B-cell lymphoma (DLBCL) are distinguished
based on molecular and immunohistochemical features. As we know, CD5 is a pan-T-cell …

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma. Aberrant expression of T antigens (exclusive of CD5) in DLBCL has been …

CD4 expression is rare in diffuse large B-cell lymphoma (DLBCL), with 4 previously reported
cases. Its significance is uncertain. We report five patients with CD4+ DLBCL and one CD4+ …

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin
lymphoma (NHL) and comprises a heterogeneous group of disease. While classification of B …

Among B-cell non-Hodgkin's lymphomas, neural cell adhesion molecule/CD56 expression
is exceptional. In this study, seven cases of CD56-positive diffuse large B-cell lymphoma …

Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma.
Although, aberrant expression of a single T-cell-associated antigen (exclusive of CD5) on …

Extranodal primary CD20-negative diffuse large B-cell lymphoma (DLBCL) is a rare tumor. It
often presents a diagnostic challenge for pathologists as the morphological features of …

De novo CD5+ diffuse large B-cell lymphoma (DLBCL) has poor survival in the era of
immunochemotherapy. Accurate gene-based typing and prognostic stratification can …

Objective To investigate the clinicopathological characteristics and immunopheotype of
diffuse large B-cell lymphoma (DLBCL) in order to improve diagnosis and therapy efficacy …